Status:

TERMINATED

Involvement of Transverso-sacral- Neo- Articulations or of Transverso-iliac Articulations in Chronic Lumbago

Lead Sponsor:

Nantes University Hospital

Conditions:

Subjects Suffering of Lateralized Lumbago on Side of the Malformation (Neo-articulation)

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

The specific aim of this study is to determine whether, when treated with corticoid infiltration, certain chronic lumbagos could be explained by the presence of a neo-articulation.The primary criteria...

Eligibility Criteria

Inclusion

  • Adult with age equal or above to 18.
  • Subject affiliated to French health insurance (Sécurité Sociale)
  • Lateralized lumbago on side of the neo-articulation evolving since more than 3 months
  • Mechanical pain, lumbar low level or gluteal without sciatic irradiation (pain above the knee)
  • Mean pain during the latest 24 hours above 4 on an analogic visual scale (from 0 to 10)- Pain induced by palpation in regards to the neo-articulation
  • Pain not relieved by medical treatment with non steroids anti- inflammatory drugs or antalgics
  • No clinical proof for a discal origin : inducing factor, impulsiveness, spinal syndrome, true Lasègue
  • transverse-sacral abnormality of IIb, IIIa, IIIc or IV type with neo-articulation lateralized on side of pain
  • Informed consent form signed

Exclusion

  • Age below 18
  • Clinical arguments in favour of a discal origin
  • Pregnant women or women that could become pregnant the day of the infiltration
  • Diabetic patient
  • Patient unable to understand the protocol
  • No autonomy for coming to the hospital (no budget allocated for patient transportation)
  • Hypersensitivity to local anesthetics with "liaison amide"
  • Hypersensitivity to one of the components
  • Porphyria- Local or generalized infection, suspiscion of infection
  • Severe troubles of coagulation, anti-coagulant treatment taken
  • Bilateral lumbago with bilateral neo-articulation

Key Trial Info

Start Date :

September 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 1 2015

Estimated Enrollment :

16 Patients enrolled

Trial Details

Trial ID

NCT01206699

Start Date

September 1 2010

End Date

February 1 2015

Last Update

November 3 2015

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Hospital of La Roche/Yon

La Roche/Yon, France, 85925

2

Nantes Hospital

Nantes, France, 44093